Search by Drug Name or NDC
NDC 00115-1710-01 Dexmethylphenidate hydrochloride 35 mg/1 Details
Dexmethylphenidate hydrochloride 35 mg/1
Dexmethylphenidate hydrochloride is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals of New York LLC. The primary component is DEXMETHYLPHENIDATE HYDROCHLORIDE.
MedlinePlus Drug Summary
Dexmethylphenidate is used as part of a treatment program to control symptoms of attention deficit hyperactivity disorder (ADHD; more difficulty focusing, controlling actions, and remaining still or quiet than other people who are the same age) in adults and children. Dexmethylphenidate is in a class of medications called central nervous system (CNS) stimulants. It works by increasing the amounts of certain natural substances in the brain.
Related Packages: 00115-1710-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Dexmethylphenidate
Product Information
| NDC | 00115-1710 |
|---|---|
| Product ID | 0115-1710_bbb45493-00cf-46d7-91bf-50f3c27a0a5d |
| Associated GPIs | 61400016107055 |
| GCN Sequence Number | 067693 |
| GCN Sequence Number Description | dexmethylphenidate HCl CPBP 50-50 35 MG ORAL |
| HIC3 | H2V |
| HIC3 Description | TX FOR ATTENTION DEFICIT-HYPERACT(ADHD)/NARCOLEPSY |
| GCN | 30306 |
| HICL Sequence Number | 022987 |
| HICL Sequence Number Description | DEXMETHYLPHENIDATE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Dexmethylphenidate hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Dexmethylphenidate hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 35 |
| Active Ingredient Units | mg/1 |
| Substance Name | DEXMETHYLPHENIDATE HYDROCHLORIDE |
| Labeler Name | Amneal Pharmaceuticals of New York LLC |
| Pharmaceutical Class | Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE] |
| DEA Schedule | CII |
| Marketing Category | ANDA |
| Application Number | ANDA203614 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00115-1710-01 (00115171001)
| NDC Package Code | 0115-1710-01 |
|---|---|
| Billing NDC | 00115171001 |
| Package | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0115-1710-01) |
| Marketing Start Date | 2017-07-05 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 2.05512 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | DEXMETHYLPHENIDATE ER 35 MG CP |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis